Rivaroxaban versus enoxaparin after total knee arthroplasty
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 2009
has subject area
- 11 Medical and Health Sciences (FoR)
- Administration, Oral (MeSH)
- Anticoagulants (MeSH)
- Arthroplasty, Replacement, Knee (MeSH)
- Clinical Trials, Phase III as Topic (MeSH)
- Drug Administration Schedule (MeSH)
- Enoxaparin (MeSH)
- Europe (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Morpholines (MeSH)
- North America (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Rivaroxaban (MeSH)
- Thiophenes (MeSH)
- Venous Thrombosis (MeSH)
published in
- The Lancet Journal